Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Perplexity launched an AI-powered web browser, Comet, with agentic AI capabilities. Know how it rivals Google Search.

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...

New Data Networks Solutions Library includes native deployment support across Google Cloud Platform, Microsoft Azure, and Amazon Web Servic ...

Discover Grok 4, the AI model redefining advanced reasoning and problem-solving. Explore its potential, challenges, and ...

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...